Several gene expression scores have been proposed for predicting the risk of recurrence, and both Tadalafil and anti-tumor vaccine-mediated immune rejection reversals also lead to up-regulation of PDL1 in recurrent HNSCC, suggesting that immune checkpoint therapy may be effective in patients with HNSCC [8]. The gene discussed is CD274; the disease is neoplasm.